-
Navigating the challenges of the Manulife-Loblaw PPN arrangement
Deals like the recent preferred provider agreement to supply specialty drugs are not only anti-competitive for business, they also restrict patients’ choice of where to obtain healthcare and ultimately, reduce the incentives for pharmacies to innovate. -
12 business resolutions for pharmacist-owners in 2024
The new year – still fresh – presents an opportunity not only to look back at all that was accomplished over the past 12 months, but also to look ahead and set priorities for the new year. That is especially the case if you are preparing to put up your pharmacy for sale within the next five years or so, because that is how long a successful business sale transaction can take in the pharmacy industry.